Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended TIR Levels for up to Two Years – Predictors of Best Efficacy
出版年份 2023 全文链接
标题
Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended TIR Levels for up to Two Years – Predictors of Best Efficacy
作者
关键词
-
出版物
Diabetes Technology & Therapeutics
Volume -, Issue -, Pages -
出版商
Mary Ann Liebert Inc
发表日期
2023-10-30
DOI
10.1089/dia.2023.0261
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- One-year follow-up comparison of two hybrid closed-loop systems in Italian children and adults with type 1 diabetes
- (2023) Marta Bassi et al. Frontiers in Endocrinology
- One‐year real‐world performance of the DBLG1 closed‐loop system: Data from 3706 adult users with type 1 diabetes in Germany
- (2023) Pierre‐Yves Benhamou et al. DIABETES OBESITY & METABOLISM
- Glycemia Risk Index As a Novel Metric to Evaluate the Safety of Glycemic Control in Children and Adolescents with Type 1 Diabetes: An Observational, Multicenter, Real-Life Cohort Study
- (2023) Claudia Piona et al. Diabetes Technology & Therapeutics
- A Meta-Analysis of Randomized Trial Outcomes for the t:slim X2 Insulin Pump with Control-IQ Technology in Youth and Adults from Age 2 to 72
- (2023) Roy W. Beck et al. Diabetes Technology & Therapeutics
- Minimed Medtronic 780G optimizes glucose control in patients with type 1 diabetes mellitus
- (2022) Basilio Pintaudi et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Predictors of time in target glucose range in real‐world users of the MiniMed 780G system
- (2022) Javier Castañeda et al. DIABETES OBESITY & METABOLISM
- CGM Metrics [Mean Glucose, Time Above Range ( % TAR ), and Time In Range ( % TIR )] are superior to HbA1c for assessment of Therapeutic Efficacy
- (2022) David Rodbard DIABETES OBESITY & METABOLISM
- Long‐term effectiveness of advanced hybrid closed loop in children and adolescents with type 1 diabetes
- (2022) Barbara Piccini et al. PEDIATRIC DIABETES
- Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study
- (2022) Pratik Choudhary et al. Lancet Diabetes & Endocrinology
- MiniMed 780G™ in 2- to 6-Year-Old Children: Safety and Clinical Outcomes After the First 12 Weeks
- (2022) Mari-Anne Pulkkinen et al. Diabetes Technology & Therapeutics
- Real world use of hybrid‐closed loop in children and young people with type 1 diabetes mellitus—a National Health Service pilot initiative in England
- (2022) Sze May Ng et al. DIABETIC MEDICINE
- The Medtronic 780G advanced hybrid closed-loop system achieves and maintains good glycaemic control in type 1 diabetes adults despite previous treatment
- (2022) Carmen Quirós et al. Endocrinologia, Diabetes y Nutricion
- A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial
- (2021) Richard M Bergenstal et al. LANCET
- Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 Diabetes
- (2021) Olivia J. Collyns et al. DIABETES CARE
- Predictors of Time-in-Range (70–180 mg/dL) Achieved Using a Closed-Loop Control System
- (2021) Melissa J. Schoelwer et al. Diabetes Technology & Therapeutics
- Real world performance of hybrid closed loop in youth, young adults, adults and older adults with type 1 diabetes: Identifying a clinical target for hybrid closed loop use
- (2021) Cari Berget et al. DIABETES OBESITY & METABOLISM
- One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology
- (2021) Marc D. Breton et al. Diabetes Technology & Therapeutics
- Design of clinical trials to assess diabetes treatment: Minimum duration of continuous glucose monitoring data to estimate time‐in‐ranges with the desired precision
- (2021) Nunzio Camerlingo et al. DIABETES OBESITY & METABOLISM
- Real-world use of a new hybrid closed-loop improves glycemic control in youth with type 1 diabetes
- (2021) Laurel H Messer et al. Diabetes Technology & Therapeutics
- Real-world Performance of the MiniMed™ 780G System: First Report of Outcomes from 4’120 Users
- (2021) Julien Da Silva et al. Diabetes Technology & Therapeutics
- Predicting Success with a First-Generation Hybrid Closed-Loop Artificial Pancreas System among Children, Adolescents, and Young Adults with Type 1 Diabetes: A Model Development and Validation Study
- (2021) Gregory P. Forlenza et al. Diabetes Technology & Therapeutics
- Six-Month Effectiveness of Advanced vs. Standard Hybrid Closed-Loop System in Children and Adolescents With Type 1 Diabetes Mellitus
- (2021) Gianluca Tornese et al. Frontiers in Endocrinology
- HbA1c Levels in Type 1 Diabetes from Early Childhood to Older Adults: A Deeper Dive into the influence of technology and socio-economic status on HbA1c in the T1D Exchange Clinic Registry Findings.
- (2020) Kellee M. Miller et al. Diabetes Technology & Therapeutics
- State of Type 1 Diabetes Care in the United States in 2016–2018 from T1D Exchange Registry Data
- (2019) David Rodbard Diabetes Technology & Therapeutics
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
- (2019) Tadej Battelino et al. DIABETES CARE
- One Year Clinical Experience of the First Commercial Hybrid Closed-Loop
- (2019) Rayhan A. Lal et al. DIABETES CARE
- Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring
- (2018) Richard M. Bergenstal et al. DIABETES CARE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now